The combination of a talquetamab and teclistamab induced durable responses among patients with relapsed or refractory ...

We described the first case reported in the literature of multiple myeloma in a young African woman with Systemic lupus and Sjögren Syndrome. The clinician should consider multiple myeloma in young ...

During a Case-Based Roundtable® event, Rahul Banerjee, MD, discussed approaches to dosing and tolerability when using ...

Experts shared diagnosis and management strategies for chronic pruritus at the Dermatology Days of Paris 2024 conference.

The combination of talquetamab and teclistamab “warrants further investigation in patients with relapsed or refractory multiple myeloma,” according to researchers.

If you have mild symptoms of an allergic reaction, such as a mild rash, call your doctor right ... in studies of Revlimid treatment for multiple myeloma. These include vision loss and high ...

Dr. Sattva S. Neelapu discusses the intricacies of CAR T-cell therapy treatment and care for patients with hematologic malignancies.

Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...

You may also notice petechia, which are small, reddish, pinprick-sized dots that form a rash on the skin. When combined with other signs of multiple myeloma, this may indicate you need to see your ...

US FDA approves Opdivo Qvantig injection, for subcutaneous use in most previously approved adult, solid tumour Opdivo indications: Princeton, New Jersey Monday, December 30, 2024, ...